Business Insider

Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...
IEEE

Impedance-Synthesized In-Band RCS Reduction for Ultrawideband Phased Array Antennas via Field–Circuit–Structure Co-Design Approach

Abstract: Achieving in-band radar cross section (RCS) in ultrawideband (UWB) phased array antennas (PAAs) is fundamentally constrained by the intrinsic coupling between radiation and scattering. This ...
IEEE

Compact Data Structures for the Metric Suffix Array

Abstract: The Metric Suffix Array (MSA) is a variant of the classical suffix array designed to support similarity queries over multimedia data. It is a permutation-base index that stores lists of ...